Brinton Pharma triples up production of COVID-19 drug Favipiravir

12 May 2021 | News

Also increased the production of additional drugs Scabover & Iverbond (Ivermectin 12 mg ) Tablet and Doxybond LB & Briodox (Doxycycline) Tablet

Image credit- shutterstock.com

Image credit- shutterstock.com

Pune based Brinton Pharmaceuticals has more than triple up the production of Faviton (Favipiravir 400) tablet, the Covid-19 drug. Favipiravir is used as an oral antiviral therapy for mild to moderate cases of Covid-19.

It has also increased the production of additional drugs Scabover & Iverbond (Ivermectin 12 mg ) Tablet and Doxybond LB & Briodox (Doxycycline) Tablet which are also used towards the treatment of covid-19.

Since Faviton helps curb mild to moderate symptoms, if taken at the right time under medical supervision, it can help cut down the trips to the hospital. This decision comes at a time where people are finding it hard to find hospital beds for their loved ones and more deaths are being seen because hospitals don’t have enough oxygen supply.

Patients are also facing shortages of these medicines that are crucial to treat the virus. At a time like this, Brinton’s call to increase productions from 15 lac to 50 lac quantity, they will further  continue to increase the production of its crucial medicines to help save many lives.

Moreover, Brinton is providing Faviton at an economical price (Rs 790/ 10 tablets) there by further helping the end patients and their families.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account